ENDOTHELIAL PROTECTION IN THE REHABILITATION OF PATIENTS WITH POSTSTROKE APHASIA
- 作者: Shishkova V.1, Remennlk A.1, Zotova L.1
-
隶属关系:
- Center for Speech Pathology and Neurorehabilitation
- 期: 卷 29, 编号 3 (2018)
- 页面: 29-35
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/117166
- DOI: https://doi.org/10.29296/25877305-2018-03-07
- ID: 117166
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
An open randomized controlled study was conducted to comprehensively examine the dynamics of recovery of speech functions and to simultaneously estimate the level of markers for endothelial dysfunction in patients with prior ischemic stroke when naftidrofuryl (Duzofarm) is incorporated into the treatment regimen.
全文:
作者简介
V. Shishkova
Center for Speech Pathology and Neurorehabilitation
Email: veronika-1306@mail.ru
Candidate of Medical Sciences Moscow
A. Remennlk
Center for Speech Pathology and NeurorehabilitationMoscow
L. Zotova
Center for Speech Pathology and NeurorehabilitationMoscow
参考
- Redon J., Olsen М., Cooper R. et al. Stroke mortality trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure // Eur. Heart J. - 2011; 32: 1424-31.
- Гусев Е.И., Скворцова В.И., Стаховская Л.В. Проблема инсульта в Российской Федерации: время активных совместных действий // Журн. неврол. и психиат. - 2007; 8: 4-10.
- Libby Р., Ridker P., Hansson G. Information in atherosclerosis from pathophysiology to practice // J. Am. Coll. Cardiol. - 2009; 54: 2129-38.
- Muller W. Mechanisms of transendothelial migration of leukocytes // Circ. Res. - 2009; 105 (3): 223-30.
- Zarbock A., Ley K. Neutrophil adhesion and activation under flow // Microcirculation. - 2009; 16 (1): 31^42.
- Luscher T., Noll G. The endothelium as a regulator of vascular tone and growth. The endothelium in cardiovascular disease: pathophysiology, clinical presentation, and pharmacotherapy / Berlin, 1995; p. 1-24.
- Poncin-Lafitte M., Grosdemouge C., Roy-Billon C. et al. Effects of naftidrofuryl on cerebral hemodynamics, metabolism and function after a retracted ischaemia // Arch. Int. Pharmacodyn. Ther. -1982; 260 (2): 218-29.
- Oudart N. Naftidrofuryl inhibits contractions to serotoninin intact and de-endothelialized cerebral arteries in vitro // J. Cardiovasc. Pharmacol. - 1990; 16 (Suppl. 3): 45-8.
- Wiemsperger N. Serotonin, 5HT receptors and brain circulation // J. Cardiovasc. Pharmacol. - 1990; 16 (Suppl. 3): 20-4. SB ВРАЧ 3 2018
- Lagrue G., Questel R. Indirect evaluation of blood oximetry by digitized conjunctival capillarography: effects of naftidrofuryl // J. Cardiovasc. Pharmacol. -1990; 16 (Suppl. 3): 67-71.
- Zander J., Aarhus L, Katusic Z. et al. Effects of naftidrofuryl on adrenergic nerves, endothelium and smooth muscle inisolated canine blood vessels // J. Pharmacol. Exp. Ther. - 1986; 239 (3): 760-7.
- Lepetit J., Dumond D., Gros J. Contrôle de l'activité du naftidrofuryl a la phase aigue des AVC par l'echopulsographietranscerebrale // Psychol. Med. - 1992; 24: 975-82.
- Kirsten R., Erdeg B., Moxter D. et al. Platelet aggregation after naftidrofuryl application in vitro and ex vivo H Int. J. Clin. Pharmacol. Ther. - 1995; 33 (2): 81-4.
- Herrmann K., Grosse-Heitmeyer A., Kreuzer H. Antithrombotic efficacy and its time course after application of naftidrofuryl in vivo // Arch. Int. Pharmacodyn. Ther.-1986; 284 (1): 145-54.
- Takeo S., Tanonaka R., Miyake K. et al. Naftidrofuryl oxalate improves impaired brain glucose metabolism after induced cerebral metabolism in rats // J. Pharmacol. Exp. Ther. - 1991; 257 (1): 404-10.
- Wiernsperger N. Serotonin, 5-HT2 receptors, and their blockade by naftidrofuryl: a targeted therapy of vascular disease // J. Cardiovasc. Pharmacol. -1994; 23 (Suppl. 3): 37-43.
- Taguchi T., Takagi N., Miyake K. et al. Effects of naftidrofuryl oxalate on microsphereinduced changes in acetylcholine and amino acid content of rat brain regions // Exp. Brain Res. - 1994; 99 (1): 7-16.
- Louis J. Effect of naftidrofuryl on metabolism and survival of cultured neurons // Neurochem. Res.-1989; 14 (12): 1195-201.
- Скворцова В.И. Принципы ранней реабилитации больных с инсультом // Журн. неврол. и психиат. (Прил.: «Инсульт»), - 2002; 7: 28-33.
- Burns М. Application of Neuroscience to Technology in Stroke Rehabilitation // Top Stroke Rehabil. - 2008; 15: 570-9.
- Лукъянюк E.B., Шкловский B.M., Малюкова Н.Г. Опыт применения акатиноламемантина в резидуальном периоде инсульта // Журн. неврол. и психиат. (Прил.: «Инсульт»), - 2010; 12: 28-33.
- Шишкова В.Н, Зотова Л.И., Кан Н.В. и др. Оценка эффективности нафтидрофурила в составе ранней комплексной реабилитации у пациентов с постинсультной афазией // Врач. - 2017; 7: 47-50.
- Шишкова В.Н., Шкловский В.М., Ременник А.Ю. и др. Новые возможности оценки нейрореабилитационного потенциала у пациентов с постинсультной афазией // Мед. алфавит. - 2016; 1: 25-9.
- Adhoute G., Barcourt F., Barrai M. et al. Naftidrofuryl in chronic arterial disease: results of a sixmonth controlled multicenter study using Naftidrofuril tablets 200 mg // Angiology. - 1994; 35: 701-8.
- Lu D., Song H., Hao Z. etal. Naftidrofuryl for dementia (Review) // Cochrane Database Syst. Rev. - 2011; 12: CD002955. doi: 10.1002/14651858.CD002955.pub4.
- de Backer T., Vander Stichele R., Lehert P. et al. Naftidrofuryl for intermittent claudication // Cochrane Database Syst. Rev. - 2012; 12: CD001368.
- Золотовская И.А., Давыдкин И.Л. Возможности фармакологической коррекции структурно-функциональных изменений в условиях эндотелиальной дисфункции у коморбидных пациентов, перенесших инсульт // Клиницист. - 2016; 2: 32-42.
补充文件
